What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Andrew L. Clark focuses on Internal medicine, Heart failure, Cardiology, Heart disease and Ejection fraction.
The study incorporates disciplines such as Endocrinology and Surgery in addition to Internal medicine.
His Heart failure research includes themes of Randomized controlled trial, Blood pressure, Intensive care medicine, Atrial fibrillation and Hazard ratio.
His study in Cardiology is interdisciplinary in nature, drawing from both Quartile, Survival analysis, Diastole and Heart rate.
His research integrates issues of Renal function, Gastroenterology, Myopathy, Circulatory system and Micronutrient in his study of Heart disease.
The Stroke volume research he does as part of his general Ejection fraction study is frequently linked to other disciplines of science, such as Functional measurement, therefore creating a link between diverse domains of science.
His most cited work include:
- The relationship between cholesterol and survival in patients with chronic heart failure. (336 citations)
- Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVE (297 citations)
- Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity (285 citations)
What are the main themes of his work throughout his whole career to date?
Andrew L. Clark spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient.
His work investigates the relationship between Heart failure and topics such as Clinical trial that intersect with problems in Randomized controlled trial.
His Internal medicine study frequently intersects with other fields, such as Surgery.
His study brings together the fields of Hazard ratio and Cardiology.
The subject of his Hazard ratio research is within the realm of Confidence interval.
His Ejection fraction study frequently draws connections between adjacent fields such as Proportional hazards model.
He most often published in these fields:
- Heart failure (78.02%)
- Internal medicine (73.07%)
- Cardiology (62.57%)
What were the highlights of his more recent work (between 2016-2021)?
- Heart failure (78.02%)
- Internal medicine (73.07%)
- Cardiology (62.57%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient.
The concepts of his Heart failure study are interwoven with issues in Interquartile range, Blood pressure, Intensive care medicine, Ambulatory and Atrial fibrillation.
His Intensive care medicine research is multidisciplinary, incorporating perspectives in Pulmonary disease, COPD, Clinical trial and Clinical significance.
Hazard ratio, Confidence interval, Natriuretic peptide, Body mass index and Malnutrition are the subjects of his Internal medicine studies.
His Cardiology research includes elements of Cardiorespiratory fitness, Renal function and Heart rate.
His study on Sacubitril, Valsartan is often connected to Weight gain as part of broader study in Ejection fraction.
Between 2016 and 2021, his most popular works were:
- Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure: A Comparison With Body Mass Index (52 citations)
- Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction (50 citations)
- Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
The scientist’s investigation covers issues in Heart failure, Internal medicine, Cardiology, Ejection fraction and Interquartile range.
His research in Heart failure intersects with topics in Prognostic models, Blood pressure, Intensive care medicine, Depression and Malnutrition.
Andrew L. Clark merges many fields, such as Internal medicine and In patient, in his writings.
His biological study spans a wide range of topics, including Clinical trial, Cardiorespiratory fitness, Hazard ratio, Spirometry and Heart rate.
His Ejection fraction research integrates issues from Creatinine, Carvedilol, Cause of death and Atrial fibrillation.
Andrew L. Clark studied Ambulatory and Central venous pressure that intersect with Malabsorption, Pulmonary artery and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
